We previously found that sarcoma CSCs indeed are found more commonly in hypoxic regions of sarcomas and that multimodal therapy with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy effectively blocks sarcoma growth through inhibition of both tumor vasculature and cancer stem-like cells21. This evidence concerns the gene VEGFA and neoplasm.